Reuters logo
BRIEF-Invitae Corp announces a program in partnership with Alnylam Pharmaceuticals
April 3, 2017 / 11:40 AM / 8 months ago

BRIEF-Invitae Corp announces a program in partnership with Alnylam Pharmaceuticals

April 3 (Reuters) - Alnylam Pharmaceuticals Inc

* Announced a program in partnership with Alnylam Pharmaceuticals to provide genetic testing for hereditary ATTR (HATTR) amyloidosis Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below